arrow
S

Stacy Todd

University of Liverpool
H指数:31
被引数:4,684

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In vitro and in situ analysis of novel copper-based antimicrobial surface coatings designed to reduce the microbial bioburden of high-touch surfaces in a hospital environment

新型铜基抗菌表面涂层的体外和原位分析:用于减少医院环境中高频接触表面的微生物生物负荷

2026-01-010
PRE
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study

降钙素原对新型冠状病毒肺炎住院患者抗生素使用的评估: 桃子混合方法研究

2025-11-010
PRE
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines

英国乙型病毒性肝炎(HBV)治疗资格:回顾性纵向队列数据,以探讨临床指南变更的影响

2025-11-010
OAAI
Health system drivers of antimicrobial resistance: a qualitative exploration of implications for infection prevention and control in hospitals and long-term care facilities in Merseyside

抗菌药物耐药性的卫生系统驱动因素:对默西塞德郡医院和长期护理机构中感染预防与控制影响的质量研究

2025-09-070
OAAI
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy

慢性乙型肝炎中不同的病毒学轨迹识别了对核苷(酸)类似物治疗的反应异质性

2025-01-012
OAAI
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19

第一波新型冠状病毒肺炎期间降钙素原检测对住院患者抗生素使用影响的回顾性倾向评分匹配队列研究

2024-09-090
OAAI
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study

降钙素原指导新型冠状病毒肺炎住院患者抗生素处方的成本效益: PEACH研究的一部分

2024-06-061
OAAI
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
2022-03-0110
OA
P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study
2022-02-160
OAAI
AAST multicenter prospective analysis of prehospital tourniquet use for extremity trauma
2022-01-1814
PRE
Age-seroprevalence curves for the multi-strain structure of influenza A virus
2021-11-1810
OAAI